title: Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity.
authors.forename: Gilles
authors.initials: G
authors.lastname: Lugassy
authors.forename: Rachel
authors.initials: R
authors.lastname: Shaham
authors.forename: Anatoly
authors.initials: A
authors.lastname: Nemets
authors.forename: David
authors.initials: D
authors.lastname: Ben-Dor
authors.forename: Oded
authors.initials: O
authors.lastname: Nahlieli
mesh_terms: D000190:Actinomyces; D000196:Actinomycosis / Q000209:etiology; D000368:Aged; D000963:Antimetabolites / Q000009:adverse effects; D004002:Clodronic Acid / Q000009:adverse effects; D005260:Female; D006801:Humans; D007568:Jaw / Q000187:drug effects* / Q000382:microbiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000401:mortality*; D009336:Necrosis; D010019:Osteomyelitis / Q000209:etiology*; D010020:Osteonecrosis / Q000209:etiology; D012720:Severity of Illness Index; D017741:Survivors
chemical_list: D000963:Antimetabolites; D004002:Clodronic Acid